KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Nektar Therapeutics (NKTR) Cost of Revenue (2016 - 2025)

Nektar Therapeutics has reported Cost of Revenue over the past 16 years, most recently at $6.8 million for Q4 2025.

  • Quarterly results put Cost of Revenue at $6.8 million for Q4 2025, down 64.6% from a year ago — trailing twelve months through Dec 2025 was $27.5 million (down 38.58% YoY), and the annual figure for FY2025 was $44.7 million, up 6.37%.
  • Cost of Revenue for Q4 2025 was $6.8 million at Nektar Therapeutics, down from $10.3 million in the prior quarter.
  • Over the last five years, Cost of Revenue for NKTR hit a ceiling of $19.3 million in Q4 2024 and a floor of $4.4 million in Q3 2024.
  • Median Cost of Revenue over the past 5 years was $7.0 million (2023), compared with a mean of $8.2 million.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 150.02% in 2023 and later tumbled 64.6% in 2025.
  • Nektar Therapeutics' Cost of Revenue stood at $6.2 million in 2021, then rose by 1.14% to $6.2 million in 2022, then skyrocketed by 69.47% to $10.6 million in 2023, then surged by 83.07% to $19.3 million in 2024, then tumbled by 64.6% to $6.8 million in 2025.
  • The last three reported values for Cost of Revenue were $6.8 million (Q4 2025), $10.3 million (Q3 2025), and $10.3 million (Q2 2025) per Business Quant data.